Drugs / Xuanfei Baidu Granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04810689 | Mar 2021 → Jun 2022 | COVID-19 | Darcy Spicer | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xuanfei Baidu Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04810689 ↗ |
| Route | Oral | “for oral intake” NCT04810689 ↗ |